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Xylene is a cyclic hydrocarbon and an environmental pollutant. It is also used in medical technology,
paints, dyes, polishes and in many industries as a solvent; therefore, an understanding of the interaction
between xylene and human lymphocytes is of significant interest. Biochemical assessment was used to
demonstrate that exposure of lymphocytes to xylene induces cytotoxicity (at 6 hr), generates intracellular
reactive oxygen species, collapse of mitochondrial membrane potential, lysosomal injury, lipid peroxida-
tion and depletion of glutathione (at 3 hr). The findings show that xylene triggers oxidative stress and
organelle damage in lymphocytes. The results of our study suggest that the use of antioxidant, mitochon-
drial and lysosomal protective agents can be helpful for individuals subject to chronic exposure to xylene.
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INTRODUCTION
Xylene is a cyclic hydrocarbon and an environmental pol-
lutant, which is known by names such as dimethyl benzene
and xylol (1). It is primarily used as a solvent in the print-
ing, rubber, cleaning agent, paint thinner, varnish, synthetic
fiber and leather industries. Contact with xylene occurs
through the eyes and skin, orally and by inhalation. Occupa-
tions in which humans are exposed to xylene include histo-
pathology laboratories, leather and rubber industries, petro-
chemicals and steel manufacturing (2-4).
Xylene has lipophilic properties. It is rapidly absorbed
through all routes of exposure and quickly distributed through-
out the body (2,5). Studies have shown that chronic occupa-
tional exposure to xylene is associated with a variety of
hematological effects (6). Decreased white blood cell counts
were observed in two women with chronic occupational
exposure to xylene (7,8). Langman et al. found that chronic
exposure to xylene is associated with thrombocytopenia,
leukopenia and anemia. Occupational exposure to xylene
significantly diminishes the percentage of lymphocytes in
the peripheral blood (2,9). Studies have reported that chil-
dren whose parents are exposed to xylene in the workplace
are at high risk for leukemia, although the females gener-
ally showed normal blood parameters (10). The current study
was designed to identify the cellular effects of xylene on lym-
phocytes in light of the findings of previous studies regarding
the probability of decreased white blood cell counts in humans
following exposure to xylene and the compound effect of
ameliorating immune system activity against viral infection.
MATERIALS AND METHODS
Blood samples. All blood samples (n = 10) were acquired
from Massoud Laboratory and approved by the Blood
Administration Center of Tehran province in Iran. The stud-
ies were performed at the Faculty of Pharmacy at Shahid
Beheshti University of Medical Sciences (Tehran, Iran)
under the guidance of an expert physician. This study was
approved by the Shahid Beheshti University of Medical Sci-
ences research ethics committee and all participants signed
informed consent forms (11).
Lymphocytes isolation. Lymphocytes were collected
from healthy individuals who were 25 to 35 years of age.
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Blood was obtained from 10 healthy, non-smoking volun-
teers who showed no signs of infection at the time the blood
samples were collected. Lymphocytes were isolated using
Ficoll-Paque Plus (GE, PA, USA) by centrifugation at
2,500 g for 20 min at 4oC. The lymphocytes were collected,
suspended in erythrocyte lysis buffer (150 mM NH4Cl,
10 mM NaHCO3, 1 mM EDTA, pH 7.4) and incubated for
5 min at 37oC. PBS was added immediately and the cells
were centrifuged at 1,500 g for 10 min at 4oC. The superna-
tant was decanted and the cells were washed twice with
PBS at 2,000 g for 7 min. The cells then were resuspended
in RPMI1640 medium with L-glutamine and 10% FBS.
The final lymphocytes count used in the experiments was
1×106 cells/mL. The viability of the lymphocytes was over
95% (12).
Lymphocyte treatment. Commercial or mixed xylene
usually contains 40% to 65% m-xylene and up to 20% each
of o-xylene, p-xylene and ethylbenzene. The mixed xylene
was first dissolved in 0.05% DMSO. The concentration of
DMSO used in the experiments was non-toxic for lympho-
cytes as analyzed by cell viability and other parameters.
The change in the untreated lymphocytes (negative con-
trols) was 100%. The final concentration of the xylene used
in the experiments was 50 to 2,000 ng/L. The cells were
incubated in xylene for 6 hr to determine cell viability and
oxidative stress mechanistic parameters within 3 hr of incu-
bation. Incubation was carried out at 37oC in 5% CO2 atmo-
sphere (11).
Cell viability. Cell viability was assessed by MTT assay
as described by Mosmann (13). In brief, lymphocytes (1 ×
104 cells/well) were incubated in 96-well plates with and
without xylene for 6 hr in a final volume of 10 µL. At the
end of treatment, 25 µL of MTT (5 mg/mL in RPMI) was
added to each well and incubated for an additional 1 hr at
37oC. The purple-blue MTT formazan precipitate was dis-
solved in 100 µL of DMSO and absorbance was measured
at 570 nm with an ELISA reader. Each concentration was
tested in three different experimental runs with three repli-
cates per sample (12).
Reactive oxygen species assay. Reactive oxygen spe-
cies (ROS) formation was measured at 1, 2 and 3 hr by
DCFH-DA staining. In brief, 950 µL of cell suspension plus
50 µL of a specific concentration of xylene were incubated
at 37oC in 5% CO2 atmosphere in 24 plates. At the end of
incubation, the cell wells were suspended and 300 µL was
removed from each group. The removed cells were washed
twice with PBS at 1,000 rpm for 5 min. After washing, the
cells were resuspended in 300 µL of PBS containing
1.6 µM DCFH-DA and incubated for 15 min. Next, 100 µL
of cells were diluted with deionized water in a cuvette and
the fluorescence intensity of the DCF was measured using a
Shimadzu RF5000U fluorescence spectrophotometer. The
excitation and emission wavelengths were 500 and 520 nm,
respectively (14).
Mitochondrial membrane potential assay. Mito-
chondrial membrane potential (MMP) collapse was meas-
ured at 1, 2 and 3 hr by rhodamine 123 staining. MMP
assay is similar to measurement of ROS except that, after
washing, the removed cells were resuspended in 300 µL
of PBS containing 1.5 µM rhodamine 123 and incubated
for 15 min. Next, 100 µL of cells were diluted with deion-
ized water in a cuvette and the fluorescence intensity of
the rhodamine 123 was measured using a Shimadzu
RF5000U fluorescence spectrophotometer. The excitation
and emission wavelengths were 490 and 520 nm, respec-
tively (14,15).
Lysosomal membrane integrity assay. Lysosomal mem-
brane integrity was measured after 1, 2 and 3 hr by acridine
orange staining. Lysosomal membrane integrity assay is
similar to measurement of ROS except that, after washing
the removed cells, they were resuspended in 300 µL of PBS
containing 5 µM of acridine orange and incubated for 15
min. Next, 100 µL of cells were diluted with deionized
water in a cuvette and the fluorescence intensity of the acri-
dine orange was measured using a Shimadzu RF5000U flu-
orescence spectrophotometer. The excitation and emission
wavelengths were 495 and 530 nm, respectively (14).
Lipid peroxidation assay. Lipid peroxidation was meas-
ured after 3 hr of exposure using the thiobarbituric acid
reactive substances (TBARS) method. Briefly, 950 µL of
cell suspension plus 50 µL of a specific concentration of
xylene were incubated at 37oC in 5% CO2 atmosphere in 24
plates. After exposure, 750 µL of the exposed cells were
combined with 250 µL of 70% trichloroacetic acid (TCA) and
1 mL of distilled water was added. After 20 min, 1 mL of
0.8% thiobarbituric acid (TBA) was added. The mixture
was placed in a boiling water bath for 20 min and then cen-
trifuged at 13,000 rpm for 10 min. The amount of TBARS
formed during the decomposition of lipid hydroperoxides
was determined by following the absorbance at 532 nm
(14,16).
GSH and GSSG. Reduced glutathione (GSH) and oxi-
dized glutathione (GSSG) were determined according to the
spectrofluorometric method. Each sample was measured in
quartz cuvettes using a fluorimeter set at 350 nm of exci-
tation and a 420 nm emission wavelength (14).
Statistical analysis. The results are presented as mean
± SD. The assays were performed in triplicate and the mean
was used for statistical analysis. Statistical significance was
determined using one-way and two-way ANOVA, followed
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by the post hoc Tukey and Bonferroni tests, respectively.
Statistical significance was set at p<0.05.
RESULTS
Cell viability. The results showed that xylene signifi-
cantly reduced the viability of lymphocytes after 6 hr of
incubation at concentrations of 1,000 to 2,000 ng/L. Fig. 1
shows xylene-induced cytotoxicity (28% and 38%) in the
treated lymphocytes at 1,000 and 2,000 ng/L, respectively.
ROS measurement. The results of ROS measurement
showed that the amount of reactive oxygen radical forma-
tion after exposure to xylene increased significantly at con-
centrations of 500~2,000 ng/L after 1, 2 and 3 hr. Fig. 2A
shows that Butylated hydroxytoluene (BHT) as an antioxi-
dant significantly reduced xylene-induced blood lympho-
cyte ROS formation. H2O2 was used as a positive control
for assessment of ROS formation. The effects of BHT, chlo-
roquine and cyclosporine A (Cs.A) on the lymphocytes
were separately tested (data not shown).
Malondialdehyde measurement. Fig. 2B showed that
a significant amount of TBARS formed only when human
blood lymphocytes were incubated in xylene at a concentra-
tion of 2,000 ng/L. Xylene-induced TBARS formation was
prevented by ROS scavenging (50 µM BHT), MPT pore
sealing agent (5 µM Cs.A) and chloroquine, a lysosomo-
tropic agent which inhibits a Fenton-type reaction. The
effects of BHT, chloroquine and Cs.A on lipid peroxidation
were separately tested (data not shown).
MMP assay. The results showed that xylene at all time
intervals (1, 2 and 3 hr) at concentrations of 500 and 2,000
ng/L significantly decreased MMP in the blood lympho-
cytes. Concurrent use of an antioxidant (BHT), lysosomal
Fenton reaction inhibitor (chloroquine) and MPT pore-
sealing agent (Cs.A) with xylene (1 µM) de- creased mito-
chondrial damage and inhibited MMP collapse. Ca+2 was
used as a positive control for assessment of MMP col-
lapse (Fig. 3). The effects of BHT, chloroquine and cyclo-
sporine A on the MMP assay were separately tested (data
not shown).
Fig. 2. Treated lymphocytes: (A) ROS formation; (B) lipid per-
oxidation. ROS formation was measured fluorometrically using
DCF-DA. Lymphocytes (106 cells/mL) were incubated in RPMI
1640 at 37oC for 3 hr following addition of xylene. TBARS for-
mation is expressed as nM. Values are expressed as mean ± SD
of three separate experiments (n = 5). *Significant difference in
comparison with untreated control (p<0.05). ***Significant dif-
ference in comparison with untreated control (p<0.001). ****Sig-
nificant difference in comparison with untreated control (p<
.001). #Significant difference in comparison with xylene-treated
lymphocytes (2,000 ng/L) and preventive agents (BHT, chloro-
quine and Cs.A) (p<0.05).
Fig. 1. Cell viability of lymphocytes from healthy donors seeded
at 1 × 104 cells/well on 96-well plates, exposed to 50~2,000 ng/L
xylene and then incubated for 6 hr. Absorbance representing
the viability of the lymphocytes was determined by ELISA at
570 nm. Data presented as mean ± SD. The significance level
was p<0.05 (n = 5). ***Denotes difference in comparison with
untreated control (p<0.001). NS: Non-significant in comparison
with untreated control.
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Lysosomal membrane leakiness assay. The results
showed that the highest concentration of xylene (2,000 ng/L)
caused lysosomal membrane damage at 1, 2 and 3 hr. Con-
current use of an antioxidant (BHT), lysosomal Fenton reac-
tion inhibitor (chloroquine) and MPT pore-sealing agents
(Cs.A, carnitine) with 2,000 ng/L of xylene prevented lyso-
somal damage and rupture of the lysosomal membrane (Fig.
4). The effects of BHT, chloroquine and Cs.A on the lyso-
somal membrane integrity were separately tested (data not
shown).
GSH and GSSG measurement. Fig. 5 shows that incu-
bation of lymphocytes in xylene at concentrations of
Fig. 3. MMP declines in xylene-treated lymphocytes compared
to those of untreated control. MMP collapse was measured by
rhodamine 123. Cs.A and BHT inhibited the decline of MMP in
lymphocytes exposed to 2,000 ng/L of xylene (p<0.001). Values
represented as percentage of MMP decline (n = 3). ***Signifi-
cant difference in comparison with untreated control (p<0.001).
†Denotes significant difference in comparison with xylene-
treated lymphocytes (p<0.05).
Fig. 4. Lymphocytes (106 cells/mL) incubated in RPMI 1640 at
37oC. Lysosomal membrane damage was determined as the dif-
ference in redistribution of acridine orange from lysosomes into
cytosol between the treated lymphocytes and untreated con-
trol lymphocytes. Results are shown as percentage of lysosomal
membrane leakiness in all treated (test) lymphocyte groups. Val-
ues are expressed as mean ± SD of three separate experiments
(n = 5). The significant difference in comparison with the con-
trol lymphocytes was p<0.05. * Significant difference in compar-
ison with untreated control (p<0.001). ***Denotes significant dif-
ference in comparison with xylene-treated lymphocytes (p<
0.001). †Denotes significant difference (p<0.05) in comparison
with lymphocytes treated with 2,000 ng/L of xylene.
Fig. 5. Lymphocytes (106 cells/mL) incubated in RPMI 1640 at
37oC for 3 hr following the addition of xylene. Fluorometrically
determined: (A) intracellular GSH and (B) extra cellular GSSG.
Values are expressed as mean ± SD of three separate experi-
ments (n = 5). *Significant difference in comparison with untreated
control  (p<0.05). ***Denotes significant difference in compari-
son with untreated control (p<0.001). #Denotes significant differ-
ence in comparison with xylene-treated lymphocytes and
preventive agent (p<0.05). ###Significant difference in compari-
son with 2,000 ng/L (p<0.001).
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500~2,000 ng/L induced rapid lymphocyte intracellular
GSH depletion (Fig. 5B). Most of the xylene-induced GSH
depletion can be attributed to the expulsion of GSSG (Fig.
5B). Again, addition of an antioxidant (BHT), MPT pore-
sealing agents (Cs.A and carnitine) and a lysosomotropic
agent (chloroquine) significantly prevented a decrease in
xylene-induced intracellular GSH and an increase in extra-
cellular GSSG. None of these reagents produced a signifi-
cant effect on lymphocyte GSH/GSSG status at the con-
centrations used (data not shown).
DISCUSSION
Decreased lymphocyte and serum complements were
detected in workers who had been heavily exposed to xylene
(8). Studies reveal adverse effects such as a decrease in the
weight of the thymus and spleen in rats exposed to 2,000
mg/kg of xylene daily (1). The results of the current study
showed that xylene is toxic to human lymphocytes at 1,000
and 2,000 ng/L after 6 hr of exposure. Studies on humans
and animals have shown that xylene is well-absorbed by
inhalation and oral routes. In the blood, it is primarily bound
to serum proteins and accumulates in adipose tissue (17).
Xylene is very soluble in blood and therefore absorbed eas-
ily into systemic circulation after exposure. This means that
it is likely to attain such high concentrations after chronic
exposure (18). Interestingly, the toxic concentrations obtained
in the current results were similar to the human exposure
levels found by Perbellini et al (19).
Studies have found that the toxicity of many organic com-
pounds appear to relate to the induction of ROS through sys-
temic elevation of the normal cellular rate of oxygen radical
generation (20-22). Studies have revealed that ROS are gen-
erated during metabolism of xylene (23). It was also recently
reported that o-xylene can induce toxicity and apoptosis
individually in Drosophila melanogaster and human leuke-
mia cells by increasing ROS production (20,23). In the
present study, ROS production was altered in cells treated
with xylene.
Previous investigations have shown that xylene is a more
effective uncoupling agent and more effective in depleting
ATP (24). Xylene is an aromatic hydrocarbon without pro-
ton releasing groups; therefore, rather than a protonopho-
retic mechanism, it binds to membrane hydrophobic sites
such as proteins, an event which enhances its flux and/or
interaction with the mitochondrial membrane targets (24).
Revilla et al. found that xylene was capable of eliciting sig-
nificant mitochondrial swelling in apparent association with
increased ROS generation (24). The current results indicate
that at the concentrations used, xylene could induce MMP
collapse and increase ROS generation. The latter was inhib-
ited by BHT as an antioxidant agent, which reflects the role
of ROS formation in mitochondrial damage.
Hydrogen peroxide is mainly produced by the mitochon-
dria and diffuses into lysosomes in abnormal amounts.
Because many lysosomes are rich in redox-active Fe2+/Fe3+
due to degradation of iron-containing macromolecules, Fen-
ton-type reactions then take place and result in lysosomal
membrane rupture with the release of powerful lytic enzymes
(25). The results of the current study showed that the use of
antioxidant and MPT pore-sealing agents inhibited lyso-
somal damage.
In recent years, it has been suggested that lipid peroxida-
tion plays an important role in toxicity induced by organic
solvents (26). The results of the present study showed that
xylene treatment of lymphocytes at 2,000 ng/L provoked
potentiation of lipid peroxidation in the membranes of lym-
phocytes. It has also been suggested that xylene-induced
lipid peroxidation may be a consequence of impairment of
antioxidant defense systems such as glutathione and gluta-
thione-related enzymes. The current study confirms these
findings. It was shown that changes in the cellular defense
system (decreased GSH content and increased GSSG) were
associated with mitochondrial damage and ROS formation.
The current study reveals that xylene is toxic to human
lymphocytes through ROS formation and mitochondrial and
lysosomal damage that results in oxidative stress, depletion
of GSH and cytotoxicity. Moreover, the current results sug-
gest that the use of antioxidants can help protect individu-
als who are at risk of exposure to industrial solvents like
xylene.
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